leisure time -WSS

leisure time

author：hotspot 2025-10-01 17:05:50 - browse：9

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： First U.S. drug developed to treat liver disease MASH is approved

WSS

HHS secretary Becerra pressed on Change HealthCare cyberattack

HHS secretary Becerra pressed on Change HealthCare cyberattack

Readout Newsletter: CAR

Change Healthcare outage fallout shows need for new oversight

Judge agrees to delay next hearing in Trump classified documents case

Create a giant ice tray with this foil pan hack to keep food cold this summer

Wikipedia

leisure time

focus

Peter Hotez and the public health issue of online harassment

Pandemic and All Hazards Preparedness Act needs lean update

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Ebola: Gilead Sciences antiviral shows promise as new treatment

Anesthesiologist group: stop taking Ozempic before surgery

Pushing for an NIH office for post

Duchenne breakthrough therapy leaves behind pioneering families

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Swim instructor mom warns parents not to buy blue swimsuits for kids

hotspot

RaDonda Vaught links Vanderbilt hospital issues to patient death

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Biden targets hefty hospital 'facility fees' that often surprise patients

Pandemic and All Hazards Preparedness Act needs lean update

The U.S. needs a new definition of substance use “recovery”

The U.S. needs a new definition of substance use “recovery”

leisure time

entertainment

Wikipedia

hotspot